Clinical Trial Update: Effects of THC-Free CBD Oil on Agitation in Patients With Alzheimer's Disease [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating effects of THC-free CBD oil on agitation in patients with Alzheimer’s disease and related dementias.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease
• Dementia
• Major Neurocognitive Disorder with Aggressive Behavior

Drugs mentioned

• THC-free CBD oil

Snippet

Sponsor: Eastern Virginia Medical School | Conditions: Alzheimer Disease, Dementia | Phase 2 | Status: UNKNOWN